Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Indinavir Sulphate bulk supplier for pharma manufacturers

Indinavir Sulphate 200 mg, 400 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 200 mg, 400 mg

Reference Brands: Crixivan®(EU & US)

Category: Anti Viral

Indinavir Capsules (200 mg, 400 mg), known as Crixivan® or Indivan®, are protease inhibitors used for HIV-1 treatment. Though less common today, they remain available for procurement on PharmaB2B platforms from WHO-GMP manufacturers—ideal for tenders, legacy treatment, and global HIV access programs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Indinavir Sulphate Capsules, marketed under brands like Crixivan® and Indivan®, are protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 management. Available in 200 mg and 400 mg strengths, Indinavir works by inhibiting viral protease enzymes, reducing HIV replication. Though newer ARVs have largely replaced it in developed countries, Indinavir remains in use in resource-limited settings. On PharmaB2B platforms, buyers can bulk source WHO-GMP-certified generics for use in HIV programs, NGO supply chains, and public tenders. Reliable, cost-effective, and essential for legacy HIV treatment protocols, Indinavir supports access to affordable antiretroviral care worldwide.

Indinavir Sulphate — third party manufacturing & bulk supply

Indinavir Sulphate 200 mg, 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Indinavir Sulphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Indinavir Sulphate →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Indinavir Sulphate is an antiretroviral medication used to treat HIV infection. It works by inhibiting the HIV protease enzyme, which prevents the virus from maturing and multiplying, thereby helping to control viral load and improve immune function.

Indinavir Sulphate is made from a synthetic protease inhibitor compound that specifically targets HIV protease to block viral replication.

A common trade name for Indinavir Sulphate is Crixivan.

Crixivan (Indinavir Sulphate) was originally manufactured by Merck & Co. Generic versions are produced by various pharmaceutical companies worldwide.

The generic name is indinavir sulfate.

The brand name is Crixivan, along with other generic brands depending on the region and manufacturer.

Indinavir Sulphate is manufactured in multiple regions, including the USA, Europe, and India, by approved pharmaceutical manufacturers.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.